Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
6.27
-0.51 (-7.52%)
At close: Jul 31, 2025, 4:00 PM
6.14
-0.13 (-2.07%)
Pre-market: Aug 1, 2025, 5:41 AM EDT

Liminatus Pharma Statistics

Total Valuation

LIMN has a market cap or net worth of $163.11 million. The enterprise value is $183.03 million.

Market Cap163.11M
Enterprise Value 183.03M

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

LIMN has 26.01 million shares outstanding. The number of shares has decreased by -74.62% in one year.

Current Share Class 26.01M
Shares Outstanding 26.01M
Shares Change (YoY) -74.62%
Shares Change (QoQ) -76.82%
Owned by Insiders (%) 35.02%
Owned by Institutions (%) 0.28%
Float 4.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9.82

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.52
52-Week Price Change n/a
50-Day Moving Average 10.44
200-Day Moving Average n/a
Relative Strength Index (RSI) 43.61
Average Volume (20 Days) 992,510

Short Selling Information

The latest short interest is 202,585, so 0.78% of the outstanding shares have been sold short.

Short Interest 202,585
Short Previous Month 174,194
Short % of Shares Out 0.78%
Short % of Float 4.50%
Short Ratio (days to cover) 0.11

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -3.33M
Pretax Income n/a
Net Income -3.55M
EBITDA n/a
EBIT -3.33M
Earnings Per Share (EPS) -$0.14
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) -1,060
Book Value Per Share -0.00
Working Capital -1,060
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.45M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LIMN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 74.62%
Shareholder Yield n/a
Earnings Yield -2.17%
FCF Yield n/a

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1